Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",22307,105,1.53 [1.13-2.07],0.005821117520115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,19786,88,1.69 [1.27-2.26],0.0003659111339432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,22917,109,2.45 [1.28-4.69],0.0070634611915639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,22802,107,1.74 [1.16-2.60],0.0077683754813107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,22917,109,2.27 [1.53-3.38],4.605106808144189e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,22362,107,2.41 [1.35-4.31],0.0029202588218887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,22768,107,2.26 [1.56-3.28],1.7018716328866838e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,22609,108,2.14 [1.51-3.02],1.617644016816147e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",22802,107,2.66 [1.52-4.64],0.0005978967942209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,22727,108,2.42 [1.27-4.64],0.0074901105612198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,19423,86,0.38 [0.19-0.73],0.0035547952165735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,22881,108,2.91 [1.46-5.80],0.002338604007115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,19307,86,3.46 [1.94-6.17],2.6625691176710247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,22722,109,2.36 [1.59-3.49],1.871275799773577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,22802,107,1.68 [1.22-2.31],0.001397374379933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,22689,107,2.34 [1.44-3.80],0.0005915986473187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,19144,84,1.72 [1.14-2.57],0.0091133667136964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22307,105,1.59 [1.18-2.15],0.002548583222525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19716,86,1.95 [1.30-2.92],0.0012072220770425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,22248,105,1.28 [1.07-1.54],0.0077177212208752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,22877,108,2.21 [1.43-3.43],0.000386018897632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,19775,88,2.06 [1.48-2.86],1.935356035566153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,22727,108,1.91 [1.17-3.11],0.0092451559315798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,22646,109,2.27 [1.36-3.79],0.0017183089271199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,22917,109,2.84 [1.46-5.55],0.0021970523416253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,22990,109,2.13 [1.55-2.92],2.784764282465258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,19786,88,1.77 [1.24-2.55],0.0018978882105069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,22818,109,2.72 [1.38-5.38],0.0039498626546428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,22722,109,1.93 [1.31-2.85],0.0009393966733006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,23006,109,2.10 [1.41-3.13],0.0002870935204661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,19125,83,1.82 [1.24-2.66],0.0021644318960913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,22802,107,2.85 [1.29-6.34],0.009933964784865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,22802,107,3.04 [1.72-5.37],0.0001253414868702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,22727,107,1.22 [1.06-1.40],0.0061811631484923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,22745,109,1.50 [1.10-2.03],0.0094124967902537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,22700,107,1.53 [1.11-2.10],0.00929918837874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,22970,109,3.40 [1.72-6.71],0.0004232009523007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,19125,83,1.42 [1.14-1.77],0.001703318348362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,23006,109,2.59 [1.27-5.26],0.0086834306323235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,22446,107,2.01 [1.28-3.17],0.0026171648911132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,22727,108,2.20 [1.22-3.96],0.0085065805551368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22609,108,2.43 [1.40-4.21],0.0016046232629464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,22917,109,2.37 [1.65-3.41],3.01796622048717e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,19224,81,2.55 [1.33-4.88],0.0048511701499869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22797,108,1.99 [1.21-3.28],0.0064811796741999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,22687,108,2.07 [1.24-3.44],0.0051576929436771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,19770,87,2.31 [1.32-4.05],0.0033003358822958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,22323,107,1.53 [1.12-2.09],0.0073871029156191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,19224,81,0.51 [0.33-0.79],0.0025704477441134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,21876,102,2.28 [1.44-3.62],0.0004762869492131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,22488,108,2.01 [1.24-3.26],0.0049170160727878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",19770,87,1.53 [1.11-2.11],0.0093785362602278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",23006,109,1.71 [1.27-2.30],0.0003813001851573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22521,108,2.07 [1.21-3.55],0.007944000263867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,22658,107,2.40 [1.53-3.76],0.000128257215058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,23006,109,2.17 [1.69-2.80],1.86509994336816e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,22140,106,1.83 [1.31-2.56],0.0004238537319659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,22890,109,2.67 [1.59-4.48],0.0001998794995759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,19224,81,1.59 [1.12-2.26],0.0091709409693629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22018,105,1.32 [1.11-1.58],0.0018187332367093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,22990,109,2.16 [1.43-3.29],0.000286591589869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,22917,109,2.00 [1.39-2.88],0.000203488848486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,22972,109,1.99 [1.51-2.63],1.2498054712104978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,22452,108,1.85 [1.37-2.49],5.975090977048155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,23006,109,1.76 [1.16-2.65],0.0075284367484524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,19760,88,1.83 [1.16-2.90],0.0095994895311492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,22700,107,2.42 [1.54-3.81],0.0001241425888617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,22214,105,1.51 [1.19-1.91],0.0007391940819731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,22687,108,3.01 [1.57-5.76],0.0008578451840351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,22700,107,1.80 [1.19-2.72],0.0055508434384636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,22609,108,1.29 [1.09-1.53],0.0028657040020974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22832,108,1.91 [1.22-2.99],0.0045960387863118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,22178,107,0.83 [0.74-0.94],0.0042039259612913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,22917,109,1.54 [1.24-1.91],9.483918506416582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,22952,108,1.57 [1.15-2.15],0.0045231972514722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,22787,109,0.64 [0.45-0.90],0.0097670800947959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,22656,108,1.50 [1.11-2.01],0.0080287632843303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,22700,107,2.74 [1.45-5.17],0.001899003004363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,19729,85,2.41 [1.71-3.40],5.019104977397363e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,22323,107,0.54 [0.35-0.82],0.0037682216957236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,23006,109,2.41 [1.49-3.89],0.0003091172711071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,22570,107,2.29 [1.39-3.76],0.0010838691248103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,22893,109,1.47 [1.21-1.80],0.0001458140525694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,22695,108,1.58 [1.19-2.09],0.001316522373057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,22727,108,1.53 [1.13-2.08],0.0060545520321239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,19192,81,0.56 [0.37-0.83],0.0045457338782946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22780,108,2.36 [1.32-4.20],0.0036435881275473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,22917,109,2.47 [1.40-4.35],0.0017474111060008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,22152,108,1.81 [1.33-2.47],0.0001784286746496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,23006,109,1.97 [1.22-3.19],0.0057559375624053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,22722,109,1.97 [1.32-2.94],0.0009237795802848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,22307,105,1.31 [1.16-1.48],1.028884603508216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,19716,86,2.02 [1.41-2.88],0.000122332737183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22722,109,1.32 [1.17-1.50],8.630596721506304e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,22507,107,1.43 [1.14-1.80],0.0021919466717294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,22609,108,0.72 [0.56-0.92],0.008300928802094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,22591,107,1.45 [1.14-1.83],0.0021877617353096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,19716,86,2.25 [1.47-3.45],0.0001976062422131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,19789,88,0.34 [0.16-0.72],0.0050897518461992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22521,108,2.25 [1.30-3.88],0.0035400560509921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,22432,107,1.64 [1.29-2.09],5.857894204605445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,22431,107,2.13 [1.39-3.26],0.0004856652371215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,22538,107,3.59 [2.18-5.90],4.784648290318291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,19789,88,0.43 [0.24-0.77],0.0048692954982023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,22323,107,1.77 [1.22-2.55],0.0023658115127102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,22700,107,1.72 [1.15-2.58],0.0085656246166164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,19095,82,1.31 [1.09-1.58],0.0049225985504293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,22741,107,2.30 [1.25-4.23],0.0072018699456567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,19398,88,1.63 [1.29-2.06],3.744022201221275e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,19321,84,0.68 [0.51-0.91],0.0094961347778152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,19729,85,1.86 [1.29-2.67],0.000818114617387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,22605,106,1.55 [1.16-2.08],0.0031605014821052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,23006,109,1.43 [1.10-1.85],0.0070165800935195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,23006,109,1.44 [1.14-1.82],0.0022125079100783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,22723,107,1.55 [1.15-2.08],0.0043299807860104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22609,108,0.53 [0.34-0.83],0.0050798458731394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,22684,107,1.74 [1.27-2.40],0.0006293836895954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,22901,108,2.28 [1.30-4.02],0.0042963328290574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,22917,109,2.64 [1.58-4.40],0.0002002124272387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,19786,88,1.65 [1.21-2.25],0.0014612949658832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,22077,107,1.86 [1.19-2.93],0.006978601948261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,22930,109,2.37 [1.37-4.12],0.0021064143840007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,23006,109,1.80 [1.19-2.73],0.005149846297272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,22178,107,1.49 [1.11-2.00],0.0087514536114334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,22917,109,1.94 [1.21-3.12],0.0060620716417025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,22727,108,1.98 [1.42-2.77],6.616852478118775e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,22700,107,1.41 [1.12-1.78],0.0032673037618264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,22723,107,2.13 [1.43-3.17],0.000202776812292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,22492,108,0.78 [0.66-0.92],0.0026267529772879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,22768,107,1.55 [1.19-2.01],0.0009839409882055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,22723,108,1.63 [1.25-2.13],0.0003146491329346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,22780,108,1.72 [1.14-2.60],0.0094493220373406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,22727,108,1.75 [1.21-2.55],0.0033178176120819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,22762,108,1.63 [1.13-2.34],0.0086068864530984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22832,108,1.73 [1.19-2.50],0.0040295498698871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,22727,108,1.72 [1.18-2.52],0.0050798812047964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22689,107,2.24 [1.33-3.79],0.0025558188952886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22723,107,1.62 [1.13-2.31],0.0082271180321298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22727,108,2.12 [1.33-3.39],0.0016146380249208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,19095,82,1.48 [1.16-1.88],0.0015100320851528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,22696,108,1.76 [1.21-2.56],0.0030538997821722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,21588,101,1.95 [1.38-2.75],0.000158410326992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,22917,109,1.92 [1.19-3.11],0.0079171646431265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,19716,86,3.28 [1.78-6.04],0.0001339940082609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,19698,87,1.31 [1.07-1.61],0.0098766032151971
